<DOC>
	<DOCNO>NCT00316498</DOCNO>
	<brief_summary>This study do conjunction trial , conduct Columbia University College Physicians Surgeons New York Royal Manchester Children 's Hospital England , examine effectiveness new drug call OGT 918 treat Niemann-Pick Type C ( NPC ) disease . Patients genetic disorder transport lipid ( fatty substance ) cell , result problem liver , spleen brain . An early sign NPC reduce ability move eye rapidly side side . These voluntary eye movement call saccade . Patients OGT 918 trial participate sub-study saccadic eye movement measure see improvement occur OGT 918 treatment . Patients Niemann-Pick Type C disease 12 year age old enrol OGT 918 trial described may eligible study . Participants vertical ( ) horizontal ( side side ) saccadic eye movement measure two time point start treatment OGT 918 12 month treatment . For test , patient sit chair head position regular eye examination ( steady chin cup headrest ) follow eye series light laser spot move screen distance 1 meter ( 3 foot ) . During test , patient wear either special recording glass , infrared goggles , special contact lenses measure eye movement . A full eye evaluation last 1 hour , eye evaluate twice . The evaluation separate time least hour , possibly day .</brief_summary>
	<brief_title>Saccadic Eye Movements Patients With Niemann-Pick Type C Disease</brief_title>
	<detailed_description>None give , verified PI .</detailed_description>
	<mesh_term>Pick Disease Brain</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Niemann-Pick Diseases</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type A</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type C</mesh_term>
	<mesh_term>Miglustat</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients NPC disease confirm abnormal cholesterol esterification abnormal filipin stain . Patients age 12 . Body weight must less 14 kg . Patients ingest capsule . EXCLUSION CRITERIA : Patients young 18 unable give inform assent and/or whose legal guardian unable provide inform consent . Patients age 18 provide inform consent and/or whose legal guardian unable provide witness informed consent . Fertile patient agree use adequate contraception throughout study three month cessation OGT 918 treatment . Patients tolerate study procedure unable travel study center require protocol . Patients currently undergo therapy investigational agent patient take drug food supplement may interfere gastrointestinal absorption motility . Patients suffer clinically significant diarrhoea ( great 3 liquid stool per day great 7 day ) without definable cause within 3 month Screening Visit , history significant gastrointestinal disorder . Patients intercurrent medical condition would render unsuitable study e.g . HIV , hepatitis infection . Patients opinion investigator ( whatever reason ) think unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 15, 2007</verification_date>
	<keyword>Eye Movement</keyword>
	<keyword>Niemann Pick C</keyword>
</DOC>